NeuroScientific Biopharmaceuticals Limited (NSB.AX)
AUD 0.04
(5.71%)
AUD 0.04
(5.71%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -1.79 Million AUD | 69.88% |
| 2023 | -5.96 Million AUD | 41.89% |
| 2022 | -10.37 Million AUD | -150.8% |
| 2021 | -3.11 Million AUD | -44.29% |
| 2020 | -2.81 Million AUD | -80.71% |
| 2019 | -1.59 Million AUD | -73.94% |
| 2018 | -917.18 Thousand AUD | -217.74% |
| 2017 | -288.67 Thousand AUD | -31.84% |
| 2016 | -319.00 AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -1.26 Million AUD | 0.0% |
| 2024 Q4 | -696.24 Thousand AUD | 0.0% |
| 2024 FY | - AUD | 67.61% |
| 2023 Q4 | -1.82 Million AUD | 0.0% |
| 2023 FY | - AUD | 41.89% |
| 2023 Q2 | -4.24 Million AUD | 0.0% |
| 2022 Q2 | -5.73 Million AUD | 0.0% |
| 2022 FY | - AUD | -150.8% |
| 2022 Q4 | -4.7 Million AUD | 0.0% |
| 2021 FY | - AUD | -44.29% |
| 2021 Q2 | -1.63 Million AUD | 0.0% |
| 2021 Q4 | -2.52 Million AUD | 0.0% |
| 2020 Q4 | -996.02 Thousand AUD | 0.0% |
| 2020 FY | - AUD | -80.71% |
| 2020 Q2 | -1.88 Million AUD | 0.0% |
| 2019 Q4 | -836.59 Thousand AUD | 0.0% |
| 2019 Q2 | -725.89 Thousand AUD | 0.0% |
| 2019 FY | - AUD | -73.94% |
| 2018 Q2 | -307.15 Thousand AUD | 0.0% |
| 2018 FY | - AUD | -217.74% |
| 2018 Q4 | -581.69 Thousand AUD | 0.0% |
| 2017 FY | - AUD | -31.84% |
| 2017 Q2 | -150.38 Thousand AUD | -100.0% |
| 2017 Q4 | -100.42 Thousand AUD | 0.0% |
| 2017 Q1 | -75.19 Thousand AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | 10.37 Million AUD | 117.313% |
| Anatara Lifesciences Ltd | -1.45 Million AUD | -23.315% |
| Zelira Therapeutics Limited | -36.44 Million AUD | 95.071% |
| Biome Australia Limited | -1.57 Million AUD | -13.815% |
| Patrys Limited | -3.49 Million AUD | 48.562% |
| Orthocell Limited | -11.68 Million AUD | 84.622% |
| Imugene Limited | -147.97 Million AUD | 98.786% |
| Noxopharm Limited | -5.94 Million AUD | 69.787% |
| PYC Therapeutics Limited | -38.11 Million AUD | 95.288% |
| Chimeric Therapeutics Limited | -11.29 Million AUD | 84.103% |
| Prescient Therapeutics Limited | -7.18 Million AUD | 75.002% |
| Proteomics International Laboratories Limited | -7.88 Million AUD | 77.226% |
| Cynata Therapeutics Limited | -9.95 Million AUD | 81.947% |
| CSL Limited | 4.73 Billion AUD | 100.038% |
| Arovella Therapeutics Limited | -8.83 Million AUD | 79.664% |
| Bio-Gene Technology Limited | -2.97 Million AUD | 39.62% |
| Clinuvel Pharmaceuticals Limited | 51.86 Million AUD | 103.464% |
| Starpharma Holdings Limited | -12.57 Million AUD | 85.718% |
| Nanollose Limited | -1.14 Million AUD | -56.484% |
| Memphasys Limited | -3.3 Million AUD | 45.694% |
| Invex Therapeutics Ltd | -720.44 Thousand AUD | -149.331% |
| Amplia Therapeutics Limited | -4.55 Million AUD | 60.604% |
| Botanix Pharmaceuticals Limited | -13.91 Million AUD | 87.095% |
| Island Pharmaceuticals Limited | -2.81 Million AUD | 36.259% |
| Race Oncology Limited | -14.2 Million AUD | 87.353% |
| Nyrada Inc. | -4.59 Million AUD | 60.918% |
| Telix Pharmaceuticals Limited | 22.96 Million AUD | 107.821% |
| Dimerix Limited | -24.95 Million AUD | 92.803% |
| PharmAust Limited | -9.45 Million AUD | 80.995% |
| Immutep Limited | -42.87 Million AUD | 95.81% |
| Clarity Pharmaceuticals Ltd | -44.64 Million AUD | 95.977% |
| Alterity Therapeutics Limited | -19.57 Million AUD | 90.822% |
| BTC Health Limited | 1.05 Million AUD | 270.218% |
| Acrux Limited | -7.93 Million AUD | 77.351% |
| Neuren Pharmaceuticals Limited | 199.26 Million AUD | 100.901% |
| Biotron Limited | -5.04 Million AUD | 64.36% |
| Tissue Repair Ltd | -5.77 Million AUD | 68.895% |
| AdAlta Limited | -5.3 Million AUD | 66.125% |
| Radiopharm Theranostics Limited | -45.37 Million AUD | 96.041% |
| Hexima Limited | -995.54 Thousand AUD | -80.433% |
| AnteoTech Limited | -11.57 Million AUD | 84.476% |
| Paradigm Biopharmaceuticals Limited | -64.53 Million AUD | 97.217% |
| Recce Pharmaceuticals Ltd | -21.35 Million AUD | 91.588% |
| Avecho Biotechnology Limited | -3.24 Million AUD | 44.602% |
| Actinogen Medical Limited | -12.92 Million AUD | 86.098% |
| Immuron Limited | -6.19 Million AUD | 70.992% |
| Argenica Therapeutics Limited | -1.89 Million AUD | 5.339% |